Usually, the primary objective in obesity or adiposity trials is to show that an intervention produces clinically meaningful, sustained reduction in body weight or excess adiposity versus control.
Pharmacological treatments for obesity serve as a valuable addition to lifestyle interventions. These interventions frequently result in only modest weight loss, which can be challenging to sustain.
Manipulation of the gut microbiota alone is insufficient to alter bodyweight
Lifestyle modifications remain the primary therapy for obesity and related metabolic disorders.
Increased fruit and vegetable intake results in a greater reduction of weight than limited intake of high-fat low-nutrient-dense foods with controlled physical activity